| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.995 | 0.003 | 0.995 | Antiinflammatory | 0.995 0.003 DBMET01644 0.995 0.003 DBMET01645 0.993 0.003 DBMET02919 0.995 0.003 DB01234 | ||
| 0.99 | 0.001 | 0.99 | Hypoxia-inducible factor 1 alpha inhibitor | 0.943 0.002 DBMET01644 0.943 0.002 DBMET01645 0.984 0.002 DBMET02919 0.99 0.001 DB01234 | ||
| 0.986 | 0.001 | 0.986 | Androgen antagonist | 0.871 0.002 DBMET01644 0.871 0.002 DBMET01645 0.823 0.002 DBMET02919 0.986 0.001 DB01234 | ||
| 0.979 | 0.001 | 0.979 | Antipruritic | 0.93 0.002 DBMET01644 0.93 0.002 DBMET01645 0.97 0.001 DBMET02919 0.979 0.001 DB01234 | ||
| 0.972 | 0.003 | 0.972 | Toll-Like receptor agonist | 0.97 0.003 DBMET01644 0.97 0.003 DBMET01645 0.932 0.004 DBMET02919 0.972 0.003 DB01234 | ||
| 0.971 | 0.003 | 0.971 | Toll-Like receptor 7 agonist | 0.97 0.003 DBMET01644 0.97 0.003 DBMET01645 0.933 0.004 DBMET02919 0.971 0.003 DB01234 | ||
| 0.966 | 0.001 | 0.966 | Androgen agonist | 0.785 0.001 DBMET01644 0.785 0.001 DBMET01645 0.651 0.001 DBMET02919 0.966 0.001 DB01234 | ||
| 0.933 | 0.001 | 0.933 | Glucocorticoid antagonist | 0.88 0.001 DBMET01644 0.88 0.001 DBMET01645 0.822 0.001 DBMET02919 0.933 0.001 DB01234 | ||
| 0.933 | 0.004 | 0.933 | Transcription factor NF kappa B inhibitor | 0.923 0.004 DBMET01644 0.923 0.004 DBMET01645 0.865 0.009 DBMET02919 0.933 0.004 DB01234 | ||
| 0.911 | 0 | 0.919 | Glucocorticoid agonist | 0.885 0 DBMET01644 0.885 0 DBMET01645 0.919 0 DBMET02919 0.911 0 DB01234 | DBMET02919 | |
| 0.874 | 0.001 | 0.874 | Progesterone antagonist | 0.792 0.001 DBMET01644 0.792 0.001 DBMET01645 0.698 0.002 DBMET02919 0.874 0.001 DB01234 | ||
| 0.875 | 0.002 | 0.875 | Interleukin 4 antagonist | 0.852 0.003 DBMET01644 0.852 0.003 DBMET01645 0.745 0.003 DBMET02919 0.875 0.002 DB01234 | ||
| 0.856 | 0 | 0.856 | Corticosteroid-like | 0.791 0 DBMET01644 0.791 0 DBMET01645 0.636 0 DBMET02919 0.856 0 DB01234 | ||
| 0.832 | 0 | 0.832 | Transcortin receptor antagonist | 0.591 0 DBMET01644 0.591 0 DBMET01645 0.347 0 DBMET02919 0.832 0 DB01234 | ||
| 0.806 | 0.004 | 0.81 | Immunosuppressant | 0.803 0.004 DBMET01644 0.803 0.004 DBMET01645 0.81 0.003 DBMET02919 0.806 0.004 DB01234 | DBMET02919 | |
| 0.772 | 0.002 | 0.772 | NOS3 expression enhancer | 0.756 0.003 DBMET01644 0.756 0.003 DBMET01645 0.733 0.003 DBMET02919 0.772 0.002 DB01234 | ||
| 0.754 | 0.001 | 0.754 | Interferon gamma antagonist | 0.666 0.001 DBMET01644 0.666 0.001 DBMET01645 0.652 0.001 DBMET02919 0.754 0.001 DB01234 | ||
| 0.726 | 0 | 0.79 | Lipocortins synthesis agonist | 0.67 0 DBMET01644 0.67 0 DBMET01645 0.79 0 DBMET02919 0.726 0 DB01234 | DBMET02919 | |
| 0.721 | 0 | 0.721 | Arachidonic acid antagonist | 0.516 0 DBMET01644 0.516 0 DBMET01645 0.6 0 DBMET02919 0.721 0 DB01234 | ||
| 0.674 | 0.002 | 0.674 | Interleukin 5 antagonist | 0.643 0.002 DBMET01644 0.643 0.002 DBMET01645 0.561 0.003 DBMET02919 0.674 0.002 DB01234 | ||
| 0.653 | 0.002 | 0.655 | Aromatase inhibitor | 0.655 0.002 DBMET01644 0.655 0.002 DBMET01645 0.65 0.002 DBMET02919 0.653 0.002 DB01234 | DBMET01645 | |
| 0.587 | 0.052 | 0.587 | Apoptosis agonist | 0.55 0.06 DBMET01644 0.55 0.06 DBMET01645 0.52 0.068 DBMET02919 0.587 0.052 DB01234 | ||
| 0.53 | 0.007 | 0.59 | P-glycoprotein inhibitor | 0.59 0.005 DBMET01644 0.59 0.005 DBMET01645 0.445 0.012 DBMET02919 0.53 0.007 DB01234 | DBMET01645 | |
| 0.512 | 0.004 | 0.512 | Lipocortins synthesis antagonist | 0.475 0.004 DBMET01644 0.475 0.004 DBMET01645 0.48 0.004 DBMET02919 0.512 0.004 DB01234 | ||
| 0.484 | 0.017 | 0.526 | Nitric oxide antagonist | 0.526 0.014 DBMET01644 0.526 0.014 DBMET01645 0.409 0.024 DBMET02919 0.484 0.017 DB01234 | DBMET01645 | |
| 0.461 | 0.004 | 0.461 | T cell inhibitor | 0.415 0.004 DBMET01644 0.415 0.004 DBMET01645 0.313 0.005 DBMET02919 0.461 0.004 DB01234 | ||
| 0.445 | 0.025 | 0.445 | Interleukin antagonist | 0.404 0.03 DBMET01644 0.404 0.03 DBMET01645 0.364 0.036 DBMET02919 0.445 0.025 DB01234 | ||
| 0.413 | 0.002 | 0.413 | Aldosterone antagonist | 0.196 0.004 DBMET01644 0.196 0.004 DBMET01645 0.329 0.003 DBMET02919 0.413 0.002 DB01234 | ||
| 0.409 | 0.033 | 0.409 | Antioxidant | 0.403 0.034 DBMET01644 0.403 0.034 DBMET01645 0.341 0.049 DBMET02919 0.409 0.033 DB01234 | ||
| 0.393 | 0.019 | 0.407 | Sodium/bile acid cotransporter inhibitor | 0.407 0.015 DBMET01644 0.407 0.015 DBMET01645 0.382 0.023 DBMET02919 0.393 0.019 DB01234 | DBMET01645 | |
| 0.386 | 0.024 | 0.386 | DNA synthesis inhibitor | 0.336 0.033 DBMET01644 0.336 0.033 DBMET01645 0.344 0.031 DBMET02919 0.386 0.024 DB01234 | ||
| 0.37 | 0.008 | 0.37 | Cytokine production inhibitor | 0.233 0.027 DBMET01644 0.233 0.027 DBMET01645 0.112 0.097 DBMET02919 0.37 0.008 DB01234 | ||
| 0.399 | 0.044 | 0.406 | Immunomodulator | 0.406 0.042 DBMET01644 0.406 0.042 DBMET01645 0.22 0.142 DBMET02919 0.399 0.044 DB01234 | DBMET01645 | |
| 0.347 | 0.001 | 0.347 | Anabolic | 0.257 0.002 DBMET01644 0.257 0.002 DBMET01645 0.233 0.002 DBMET02919 0.347 0.001 DB01234 | ||
| 0.326 | 0.004 | 0.326 | Mineralocorticoid receptor antagonist | 0.244 0.004 DBMET01644 0.244 0.004 DBMET01645 0.252 0.004 DBMET02919 0.326 0.004 DB01234 | ||
| 0.367 | 0.06 | 0.367 | Immunostimulant | 0.285 0.083 DBMET01644 0.285 0.083 DBMET01645 0.185 0.13 DBMET02919 0.367 0.06 DB01234 | ||
| 0.282 | 0.004 | 0.282 | Inducible nitric-oxide synthase inhibitor | 0.242 0.005 DBMET01644 0.242 0.005 DBMET01645 0.219 0.007 DBMET02919 0.282 0.004 DB01234 | ||
| 0.289 | 0.026 | 0.289 | Thrombolytic | 0.251 0.033 DBMET01644 0.251 0.033 DBMET01645 0.193 0.055 DBMET02919 0.289 0.026 DB01234 | ||
| 0.28 | 0.022 | 0.28 | Tumour necrosis factor antagonist | 0.198 0.054 DBMET01644 0.198 0.054 DBMET01645 0.161 0.087 DBMET02919 0.28 0.022 DB01234 | ||
| 0.254 | 0.022 | 0.259 | Interleukin 6 antagonist | 0.259 0.021 DBMET01644 0.259 0.021 DBMET01645 0.213 0.034 DBMET02919 0.254 0.022 DB01234 | DBMET01645 | |
| 0.244 | 0.028 | 0.244 | Lipid peroxidase inhibitor | 0.196 0.043 DBMET01644 0.196 0.043 DBMET01645 0.239 0.029 DBMET02919 0.244 0.028 DB01234 | ||
| 0.214 | 0.011 | 0.214 | Estrogen antagonist | 0.175 0.017 DBMET01644 0.175 0.017 DBMET01645 0.192 0.014 DBMET02919 0.214 0.011 DB01234 | ||
| 0.245 | 0.045 | 0.264 | Hepatoprotectant | 0.264 0.04 DBMET01644 0.264 0.04 DBMET01645 0.237 0.047 DBMET02919 0.245 0.045 DB01234 | DBMET01645 | |
| 0.33 | 0.138 | 0.33 | Cyclophilin D inhibitor | 0.26 0.201 DBMET01644 0.26 0.201 DBMET01645 0.292 0.17 DBMET02919 0.33 0.138 DB01234 | ||
| 0.281 | 0.088 | 0.281 | Interleukin 2 agonist | 0.204 0.182 DBMET01644 0.204 0.182 DBMET01645 0.251 0.117 DBMET02919 0.281 0.088 DB01234 | ||
| 0.259 | 0.071 | 0.259 | Tumour necrosis factor alpha release inhibitor | 0.224 0.09 DBMET01644 0.224 0.09 DBMET01645 0.259 0.071 DB01234 | ||
| 0.284 | 0.102 | 0.299 | Cholesterol antagonist | 0.184 0.179 DBMET01644 0.184 0.179 DBMET01645 0.299 0.092 DBMET02919 0.284 0.102 DB01234 | DBMET02919 | |
| 0.191 | 0.016 | 0.191 | Topoisomerase II alpha inhibitor | 0.166 0.02 DBMET01644 0.166 0.02 DBMET01645 0.19 0.016 DBMET02919 0.191 0.016 DB01234 | ||
| 0.224 | 0.062 | 0.224 | Anesthetic general | 0.139 0.126 DBMET01644 0.139 0.126 DBMET01645 0.203 0.073 DBMET02919 0.224 0.062 DB01234 | ||
| 0.195 | 0.034 | 0.195 | Topoisomerase II inhibitor | 0.171 0.041 DBMET01644 0.171 0.041 DBMET01645 0.193 0.035 DBMET02919 0.195 0.034 DB01234 | ||
| 0.297 | 0.137 | 0.345 | Antibacterial | 0.345 0.105 DBMET01644 0.345 0.105 DBMET01645 0.297 0.137 DB01234 | DBMET01645 | |
| 0.178 | 0.02 | 0.178 | Antineoplastic alkaloid | 0.173 0.021 DBMET01644 0.173 0.021 DBMET01645 0.167 0.023 DBMET02919 0.178 0.02 DB01234 | ||
| 0.2 | 0.044 | 0.2 | Diuretic | 0.114 0.112 DBMET01644 0.114 0.112 DBMET01645 0.155 0.073 DBMET02919 0.2 0.044 DB01234 | ||
| 0.159 | 0.006 | 0.165 | 5-Alpha-reductase inhibitor | 0.064 0.015 DBMET01644 0.064 0.015 DBMET01645 0.165 0.006 DBMET02919 0.159 0.006 DB01234 | DBMET02919 | |
| 0.17 | 0.023 | 0.17 | Interleukin 8 antagonist | 0.128 0.052 DBMET02919 0.17 0.023 DB01234 | ||
| 0.171 | 0.026 | 0.199 | Antineoplastic antibiotic | 0.199 0.021 DBMET01644 0.199 0.021 DBMET01645 0.158 0.029 DBMET02919 0.171 0.026 DB01234 | DBMET01645 | |
| 0.144 | 0.003 | 0.144 | Progesterone agonist | 0.122 0.003 DBMET01644 0.122 0.003 DBMET01645 0.131 0.003 DBMET02919 0.144 0.003 DB01234 | ||
| 0.145 | 0.012 | 0.158 | Estrogen agonist | 0.104 0.016 DBMET01644 0.104 0.016 DBMET01645 0.158 0.011 DBMET02919 0.145 0.012 DB01234 | DBMET02919 | |
| 0.134 | 0.003 | 0.134 | Nitric oxide donor | 0.131 0.003 DBMET01644 0.131 0.003 DBMET01645 0.123 0.004 DBMET02919 0.134 0.003 DB01234 | ||
| 0.254 | 0.124 | 0.319 | Apoptosis antagonist | 0.319 0.073 DBMET01644 0.319 0.073 DBMET01645 0.224 0.152 DBMET02919 0.254 0.124 DB01234 | DBMET01645 | |
| 0.202 | 0.075 | 0.202 | Neurotrophic factor enhancer | 0.189 0.087 DBMET01644 0.189 0.087 DBMET01645 0.19 0.086 DBMET02919 0.202 0.075 DB01234 | ||
| 0.16 | 0.04 | 0.16 | Cholesterol synthesis inhibitor | 0.113 0.071 DBMET01644 0.113 0.071 DBMET01645 0.132 0.055 DBMET02919 0.16 0.04 DB01234 | ||
| 0.167 | 0.06 | 0.167 | Acetylcholine M1 receptor antagonist | 0.118 0.112 DBMET01644 0.118 0.112 DBMET01645 0.167 0.06 DB01234 | ||
| 0.119 | 0.017 | 0.119 | Na+ K+ transporting ATPase inhibitor | 0.107 0.025 DBMET01644 0.107 0.025 DBMET01645 0.11 0.023 DBMET02919 0.119 0.017 DB01234 | ||
| 0.107 | 0.006 | 0.107 | RNA-directed RNA polymerase stimulant | 0.064 0.01 DBMET01644 0.064 0.01 DBMET01645 0.097 0.006 DBMET02919 0.107 0.006 DB01234 | ||
| 0.149 | 0.054 | 0.149 | Farnesoid X receptor antagonist | 0.137 0.07 DBMET01644 0.137 0.07 DBMET01645 0.144 0.059 DBMET02919 0.149 0.054 DB01234 | ||
| 0.079 | 0.004 | 0.087 | Glucose-6-phosphate dehydrogenase inhibitor | 0.078 0.004 DBMET01644 0.078 0.004 DBMET01645 0.087 0.004 DBMET02919 0.079 0.004 DB01234 | DBMET02919 | |
| 0.184 | 0.111 | 0.184 | Antiamyloidogenic | 0.184 0.111 DB01234 | ||
| 0.127 | 0.054 | 0.127 | DNA intercalator | 0.102 0.072 DBMET01644 0.102 0.072 DBMET01645 0.125 0.055 DBMET02919 0.127 0.054 DB01234 | ||
| 0.152 | 0.079 | 0.152 | Melanin inhibitor | 0.152 0.079 DB01234 | ||
| 0.112 | 0.043 | 0.114 | Estrogen receptor beta antagonist | 0.101 0.063 DBMET01644 0.101 0.063 DBMET01645 0.114 0.04 DBMET02919 0.112 0.043 DB01234 | DBMET02919 | |
| 0.085 | 0.019 | 0.085 | Matrix metalloproteinase 1 inhibitor | 0.062 0.03 DBMET01644 0.062 0.03 DBMET01645 0.085 0.019 DB01234 | ||
| 0.179 | 0.117 | 0.184 | Aldehyde oxidase inhibitor | 0.184 0.114 DBMET02919 0.179 0.117 DB01234 | DBMET02919 | |
| 0.094 | 0.031 | 0.094 | Estrogen receptor alpha antagonist | 0.078 0.052 DBMET01644 0.078 0.052 DBMET01645 0.08 0.049 DBMET02919 0.094 0.031 DB01234 | ||
| 0.075 | 0.013 | 0.075 | Estrogen receptor alpha agonist | 0.036 0.023 DBMET01644 0.036 0.023 DBMET01645 0.061 0.015 DBMET02919 0.075 0.013 DB01234 | ||
| 0.139 | 0.077 | 0.139 | Ca2+-transporting ATPase inhibitor | 0.139 0.077 DBMET01644 0.139 0.077 DBMET01645 0.132 0.107 DBMET02919 0.139 0.077 DB01234 | ||
| 0.12 | 0.06 | 0.121 | Microtubule formation inhibitor | 0.121 0.06 DBMET01644 0.121 0.06 DBMET01645 0.12 0.06 DB01234 | DBMET01645 | |
| 0.107 | 0.05 | 0.107 | Nitric-oxide synthase inhibitor | 0.096 0.066 DBMET02919 0.107 0.05 DB01234 | ||
| 0.066 | 0.016 | 0.066 | Estrogen receptor beta agonist | 0.048 0.019 DBMET02919 0.066 0.016 DB01234 | ||
| 0.081 | 0.036 | 0.081 | Matrix metalloproteinase inhibitor | 0.059 0.056 DBMET01644 0.059 0.056 DBMET01645 0.081 0.036 DB01234 | ||
| 0.057 | 0.018 | 0.057 | Microtubule stabilization | 0.057 0.019 DBMET01644 0.057 0.019 DBMET01645 0.047 0.032 DBMET02919 0.057 0.018 DB01234 | ||
| 0.066 | 0.031 | 0.07 | Heme oxygenase stimulant | 0.059 0.049 DBMET01644 0.059 0.049 DBMET01645 0.07 0.025 DBMET02919 0.066 0.031 DB01234 | DBMET02919 | |
| 0.155 | 0.126 | 0.155 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.155 0.126 DB01234 | ||
| 0.035 | 0.008 | 0.055 | 5-Alpha-reductase 2 inhibitor | 0.055 0.007 DBMET02919 0.035 0.008 DB01234 | DBMET02919 | |
| 0.105 | 0.081 | 0.105 | DNA polymerase I inhibitor | 0.105 0.081 DB01234 | ||
| 0.148 | 0.124 | 0.148 | Angiogenesis stimulant | 0.148 0.124 DB01234 | ||
| 0.083 | 0.063 | 0.083 | Transcription factor NF kappa B stimulant | 0.083 0.062 DBMET01644 0.083 0.062 DBMET01645 0.083 0.063 DB01234 | ||
| 0.03 | 0.01 | 0.035 | Estrone sulfatase inhibitor | 0.02 0.017 DBMET01644 0.02 0.017 DBMET01645 0.035 0.009 DBMET02919 0.03 0.01 DB01234 | DBMET02919 | |
| 0.127 | 0.108 | 0.127 | Pregnane X receptor agonist | 0.127 0.108 DB01234 | ||
| 0.053 | 0.038 | 0.058 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.058 0.032 DBMET02919 0.053 0.038 DB01234 | DBMET02919 | |
| 0.019 | 0.011 | 0.032 | 5-Alpha-reductase 1 inhibitor | 0.032 0.008 DBMET02919 0.019 0.011 DB01234 | DBMET02919 | |
| 0.19 | 0.186 | 0.249 | Caspase 3 stimulant | 0.249 0.113 DBMET01644 0.249 0.113 DBMET01645 0.19 0.186 DB01234 | DBMET01645 | |
| 0.012 | 0.008 | 0.013 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.013 0.007 DBMET02919 0.012 0.008 DB01234 | DBMET02919 | |
| 0.042 | 0.05 | 0.048 | Protein 50S ribosomal subunit inhibitor | 0.048 0.042 DBMET01644 0.048 0.042 DBMET01645 | DBMET01645 | |
| 0.032 | 0.092 | 0.091 | HIV-1 integrase (Strand Transfer) inhibitor | 0.091 0.026 DBMET01644 0.091 0.026 DBMET01645 | DBMET01645 | |
| 0.027 | 0.158 | 0.072 | HIV-1 integrase (3'-Processing) inhibitor | 0.072 0.038 DBMET01644 0.072 0.038 DBMET01645 | DBMET01645 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |